Headlines about Simulations Plus (NASDAQ:SLP) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Simulations Plus earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 47.6808058541758 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Simulations Plus (SLP) opened at 17.10 on Friday. The company has a market cap of $294.89 million, a price-to-earnings ratio of 54.29 and a beta of -0.70. Simulations Plus has a 12 month low of $8.21 and a 12 month high of $17.40. The company has a 50-day moving average of $15.40 and a 200-day moving average of $13.36.
Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Friday, July 14th. The technology company reported $0.13 EPS for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.02. The firm had revenue of $6.75 million during the quarter, compared to analyst estimates of $6.48 million. Simulations Plus had a return on equity of 23.21% and a net margin of 24.86%. Analysts predict that Simulations Plus will post $0.32 EPS for the current year.
Several analysts recently issued reports on the stock. BidaskClub raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a report on Thursday, October 5th. Zacks Investment Research upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating and set a $17.00 target price for the company in a research note on Tuesday, July 25th.
TRADEMARK VIOLATION NOTICE: This article was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/10/13/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-simulations-plus-slp-stock-price.html.
In other news, major shareholder Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction dated Wednesday, September 27th. The stock was sold at an average price of $15.45, for a total transaction of $285,825.00. Following the transaction, the insider now owns 5,647,916 shares in the company, valued at approximately $87,260,302.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 36.93% of the stock is currently owned by insiders.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.